Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom manufacturing solutions services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2015, ended December 31, 2014.



from The Medical News http://ift.tt/1A6uK6x